Gather data to inform malaria control policies

Although malaria has long been a major health problem in Guinea-Bissau, recent studies show declining prevalence in the capital city of Bissau. Decreasing prevalence is not, however, mirrored by declines in diagnoses or prescriptions of anti-malaria drugs.

IANPHI is funding a research study to evaluate the epidemiology of malaria in Bissau and in the country’s rural areas. The research will also address the population consequences of national health policies for malaria control, including introduction of a new and more costly anti-malaria drug. Results will provide the national health system with a better understanding of the malaria situation and inform policies on cost-effective interventions.

The seed grant research is being performed within the Bandim Health Project, a research site with long experience in evaluation of the impact of health interventions. The project will be implemented in collaboration with the country’s National Laboratory of Public Health (NLPH). Both Bandim and NLPH are components of Guinea-Bissau’s new NPHI. 

Other partners in the malaria study are Statens Serum Institut (Denmark), Karolinska Institute (Sweden), and Medical Research Council (The Gambia).

Learn more about Guinea-Bissau’s new NPHI, known as INASA >>